Intuitive Surgical, Inc. (ISRG)
Intuitive Surgical, Inc. (ISRG) Q2 2025 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ:ISRG ) Q2 2025 Earnings Conference Call July 22, 2025 4:30 PM ET Company Participants David J. Rosa - CEO & Director Jamie E.
Intuitive Surgical (ISRG) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Intuitive Surgical (ISRG) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Top Estimates
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.19 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.78 per share a year ago.
Intuitive Surgical: If You're Looking For A Dip To Buy, Get It Now (Rating Upgrade)
Intuitive Surgical's premium valuation is justified by consistent mid-teens growth, a dominant market position, and a resilient razor-and-blade business model. Recent innovations like telesurgery and regulatory approvals further expand the company's total addressable market and reinforce its competitive moat. Risks include potential tariff impacts and capital return missteps, but a strong balance sheet and recurring revenues mitigate these concerns.
ISRG vs. SYK: Which Robotic Surgery Stock Is the Stronger Buy Today?
As robotic-assisted surgery continues its rising adoption in modern medicine, two industry leaders — Intuitive Surgical ISRG and Stryker SYK — are shaping the future of robotic-assisted surgery. Intuitive, renowned for its da Vinci Surgical System, continues to dominate the soft tissue surgery space.
ISRG Stock Before Q2 Earnings Release: To Buy or Not to Buy?
Intuitive Surgical's second-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
ISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA Approval
Intuitive Surgical wins FDA nod for its Vessel Sealer Curved, boosting the da Vinci system's precision and multifunctional capabilities.
Unlocking Q2 Potential of Intuitive Surgical (ISRG): Exploring Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Intuitive Surgical (ISRG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Hospital Capex Headwind: Temporary Setback or Lasting Risk for ISRG?
Intuitive Surgical's global da Vinci growth faces resistance as hospital CapEx tightens abroad, testing leasing and utilization strategies.
Why Intuitive Surgical, Inc. (ISRG) Dipped More Than Broader Market Today
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $512.06, denoting a -2.66% move from the preceding trading day.
ISRG Expands Installed Base, But Is Utilization Keeping Pace?
Intuitive Surgical's installed base tops 10,000, but flat utilization growth raises questions about ROI and system productivity.
